3 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 1 | 1 | Recruiting 1 |
Follow Solid Cancers: new trials by email Literature Review of Solid Cancers trials Research Report on Solid Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors Tunlametinib - Solid Cancers | Phase 2 | Recruiting | Tianjin Medical University Second Hospital | 15 | 2027-08-31 | 2025-09-12 |
| An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg - Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1 / Phase 2 | Recruiting | Beijing Tide Pharmaceutical Co., Ltd | 266 | 2025-12-03 | 2026-01-28 |
| Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors lattice radiation therapy - Solid Cancers, Radiotherapy | Phase 2 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 30 | 2025-07-01 | 2026-04-29 |
Ataxia Telangiectasia (1) · Carcinoma, Non-Small-Cell Lung (1) · Endometrial Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Stomach Neoplasms (1)
Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Ataxia (1) · Brain Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebellar Ataxia (1) · Cerebellar Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Beijing Tide Pharmaceutical Co., Ltd (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Tianjin Medical University Second Hospital (1)
China (3)